IL214805A0 - Estrogen receptor ligands and methods of use thereof - Google Patents

Estrogen receptor ligands and methods of use thereof

Info

Publication number
IL214805A0
IL214805A0 IL214805A IL21480511A IL214805A0 IL 214805 A0 IL214805 A0 IL 214805A0 IL 214805 A IL214805 A IL 214805A IL 21480511 A IL21480511 A IL 21480511A IL 214805 A0 IL214805 A0 IL 214805A0
Authority
IL
Israel
Prior art keywords
methods
estrogen receptor
receptor ligands
ligands
estrogen
Prior art date
Application number
IL214805A
Other languages
English (en)
Original Assignee
Gtx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtx Inc filed Critical Gtx Inc
Publication of IL214805A0 publication Critical patent/IL214805A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/42—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of mineralocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pain & Pain Management (AREA)
IL214805A 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof IL214805A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US15470709P 2009-02-23 2009-02-23
US16898309P 2009-04-14 2009-04-14
US26166909P 2009-11-16 2009-11-16
PCT/US2010/025032 WO2010096801A1 (en) 2009-02-23 2010-02-23 Estrogen receptor ligands and methods of use thereof

Publications (1)

Publication Number Publication Date
IL214805A0 true IL214805A0 (en) 2011-11-30

Family

ID=42634248

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214805A IL214805A0 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof

Country Status (10)

Country Link
EP (1) EP2398322A4 (zh)
JP (1) JP5611991B2 (zh)
KR (3) KR20150135547A (zh)
CN (1) CN102413692B (zh)
BR (1) BR112014004008A2 (zh)
CA (1) CA2753436C (zh)
IL (1) IL214805A0 (zh)
MX (1) MX340753B (zh)
RU (1) RU2543339C2 (zh)
WO (1) WO2010096801A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
WO2010141630A1 (en) * 2009-06-03 2010-12-09 University Of Southern California Compositions and methods for treatment of cancer by disrupting the lh/lhr signaling pathway
IN2014DN01959A (zh) * 2011-08-23 2015-05-15 Gtx Inc
WO2013142390A1 (en) * 2012-03-21 2013-09-26 Gtx, Inc. Aldo-keto reductase subfamily 1c3 (akr1c3) inhibitors
WO2014039820A1 (en) * 2012-09-07 2014-03-13 Gtx, Inc. Aldo-keto reductase subfamily 1c3 (akr1c3) inhibitors
WO2023220117A1 (en) * 2022-05-10 2023-11-16 Arizona Board Of Regents On Behalf Of The University Of Arizona Methods of treating dilated cardiomyopathy and heart failure

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192310A1 (en) * 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance
US20060287282A1 (en) * 2001-06-25 2006-12-21 Steiner Mitchell S Compositions comprising a SARM ad GnRH agonist or a GnRH antagonist, and methods of use thereof
US7601739B2 (en) * 2003-08-08 2009-10-13 Virgina Commonwealth University Compounds having antiestrogenic and tissue selective estrogenic properties, and compounds with anti-androgenic properties for treatment of prostate cancer and androgen receptor dependent diseases
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
CN102702013B (zh) * 2005-11-28 2016-02-10 Gtx公司 核受体结合剂
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof

Also Published As

Publication number Publication date
MX340753B (es) 2016-07-25
EP2398322A4 (en) 2012-12-05
CA2753436A1 (en) 2010-08-26
JP5611991B2 (ja) 2014-10-22
AU2010215809A1 (en) 2011-09-22
RU2543339C2 (ru) 2015-02-27
KR20150135547A (ko) 2015-12-02
BR112014004008A2 (pt) 2017-03-28
KR101458539B1 (ko) 2014-11-10
KR20130101146A (ko) 2013-09-12
WO2010096801A1 (en) 2010-08-26
EP2398322A1 (en) 2011-12-28
JP2012518654A (ja) 2012-08-16
MX2011008879A (es) 2012-04-30
CA2753436C (en) 2016-05-24
CN102413692A (zh) 2012-04-11
KR20110131227A (ko) 2011-12-06
RU2011137324A (ru) 2013-03-27
CN102413692B (zh) 2015-01-07

Similar Documents

Publication Publication Date Title
IL250624B (en) Anti-fgfr3 antibodies and methods of using them
GB2483736B (en) Estrogen receptor modulators and uses thereof
EP2427479A4 (en) ANTIBODIES AND METHODS OF USE THEREOF
ZA201105791B (en) New adenosine receptor ligands and uses thereof
IL214805A0 (en) Estrogen receptor ligands and methods of use thereof
ZA201208603B (en) Estrogen receptor modulators and uses thereof
IL215795A0 (en) Anti-il-17f antibodies and methods of use thereof
EP2464227A4 (en) COMPOUNDS AND METHODS OF USE
EP2543008A4 (en) METHODS AND APPARATUS FOR FACILITATING LOCATION SELECTION
EP2538780A4 (en) STROGEN RECEPTOR LIGANDS AND METHODS OF USE
IL219136A0 (en) Anti-hepsin antibodies and methods using same
EP2419561A4 (en) COATED FABRIC AND RELATED METHODS
EP2406244A4 (en) ESTROGEN COMPOUNDS AND METHOD FOR THEIR USE
GB2467764B (en) Attachment means and methods
IL231070A0 (en) Estrogen receptor ligands and methods of their use
GB201011673D0 (en) Up and down bowl
HK1174620A1 (zh) 吲唑基取代的二氫異噁唑並吡啶及其使用方法